Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.

Autores
Blois, Sandra M.; Tirado González, Irene; Wu, Julie; Barrientos, Gabriela Laura; Johnson, Briana; Warren, James; Freitag, Nancy; Klapp, Burghard F.; Irmak, Ster; Ergun, Suleyman; Dveskler, Gabriela S.
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Mouse and human pregnancy-specific glycoproteins (PSG) are known to exert immunomodulatory functions during pregnancy by inducing maternal leukocytes to secrete anti-inflammatory cytokines that promote a tolerogenic decidual microenvironment. Many such anti-inflammatory mediators also function as proangiogenic factors, which, along with the reported association of murine PSG with the uterine vasculature, suggest that PSG may contribute to the vascular adaptations necessary for successful implantation and placental development. We observed that PSG22 is strongly expressed around the embryonic crypt on Gestation Day 5.5, indicating that trophoblast giant cells are the main source of PSG22 during the early stages of pregnancy. PSG22 treatment up-regulated the secretion of transforming growth factor beta 1 and vascular endothelial growth factor A (VEGFA) in murine macrophages, uterine dendritic cells, and natural killer cells. A possible role of PSGs in uteroplacental angiogenesis is further supported by the finding that incubation of endothelial cells with PSG22 resulted in the formation of tubes in the presence and absence of VEGFA. We determined that PSG22, like human PSG1 and murine PSG17 and PSG23, binds to the heparan sulfate chains in syndecans. Therefore, our findings indicate that despite the independent evolution and expansion of human and rodent PSG, members in both families have conserved functions that include their ability to induce anti-inflammatory cytokines and proangiogenic factors as well as to induce the formation of capillary structures by endothelial cells. In summary, our results indicate that PSG22, the most abundant PSG expressed during mouse early pregnancy, is likely a major contributor to the establishment of a successful pregnancy.
Fil: Blois, Sandra M.. University Medicine of Berlin; Alemania
Fil: Tirado González, Irene. University Medicine of Berlin; Alemania
Fil: Wu, Julie. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Barrientos, Gabriela Laura. University Medicine of Berlin; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Johnson, Briana. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Warren, James. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Freitag, Nancy. University Medicine of Berlin; Alemania
Fil: Klapp, Burghard F.. University Medicine of Berlin; Alemania
Fil: Irmak, Ster. University of Duisburg Essen; Alemania
Fil: Ergun, Suleyman. Julius Maximilians Universitat Wurzburg. Biozentrum; Alemania
Fil: Dveskler, Gabriela S.. Uniformed Services University of the Health Sciences; Estados Unidos
Materia
implantation
pregnancy
trophoblast
angiogenesis
pregnancy specific glycoprotein 22
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/216458

id CONICETDig_f0ad0678faafa1b73a3aed6caa19b85d
oai_identifier_str oai:ri.conicet.gov.ar:11336/216458
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.Blois, Sandra M.Tirado González, IreneWu, JulieBarrientos, Gabriela LauraJohnson, BrianaWarren, JamesFreitag, NancyKlapp, Burghard F.Irmak, SterErgun, SuleymanDveskler, Gabriela S.implantationpregnancytrophoblastangiogenesispregnancy specific glycoprotein 22https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Mouse and human pregnancy-specific glycoproteins (PSG) are known to exert immunomodulatory functions during pregnancy by inducing maternal leukocytes to secrete anti-inflammatory cytokines that promote a tolerogenic decidual microenvironment. Many such anti-inflammatory mediators also function as proangiogenic factors, which, along with the reported association of murine PSG with the uterine vasculature, suggest that PSG may contribute to the vascular adaptations necessary for successful implantation and placental development. We observed that PSG22 is strongly expressed around the embryonic crypt on Gestation Day 5.5, indicating that trophoblast giant cells are the main source of PSG22 during the early stages of pregnancy. PSG22 treatment up-regulated the secretion of transforming growth factor beta 1 and vascular endothelial growth factor A (VEGFA) in murine macrophages, uterine dendritic cells, and natural killer cells. A possible role of PSGs in uteroplacental angiogenesis is further supported by the finding that incubation of endothelial cells with PSG22 resulted in the formation of tubes in the presence and absence of VEGFA. We determined that PSG22, like human PSG1 and murine PSG17 and PSG23, binds to the heparan sulfate chains in syndecans. Therefore, our findings indicate that despite the independent evolution and expansion of human and rodent PSG, members in both families have conserved functions that include their ability to induce anti-inflammatory cytokines and proangiogenic factors as well as to induce the formation of capillary structures by endothelial cells. In summary, our results indicate that PSG22, the most abundant PSG expressed during mouse early pregnancy, is likely a major contributor to the establishment of a successful pregnancy.Fil: Blois, Sandra M.. University Medicine of Berlin; AlemaniaFil: Tirado González, Irene. University Medicine of Berlin; AlemaniaFil: Wu, Julie. Uniformed Services University of the Health Sciences; Estados UnidosFil: Barrientos, Gabriela Laura. University Medicine of Berlin; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Johnson, Briana. Uniformed Services University of the Health Sciences; Estados UnidosFil: Warren, James. Uniformed Services University of the Health Sciences; Estados UnidosFil: Freitag, Nancy. University Medicine of Berlin; AlemaniaFil: Klapp, Burghard F.. University Medicine of Berlin; AlemaniaFil: Irmak, Ster. University of Duisburg Essen; AlemaniaFil: Ergun, Suleyman. Julius Maximilians Universitat Wurzburg. Biozentrum; AlemaniaFil: Dveskler, Gabriela S.. Uniformed Services University of the Health Sciences; Estados UnidosSociety for the Study of Reproduction2012-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/216458Blois, Sandra M.; Tirado González, Irene; Wu, Julie; Barrientos, Gabriela Laura; Johnson, Briana; et al.; Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.; Society for the Study of Reproduction; Biology Of Reproduction (online); 86; 6; 6-2012; 1-90006-3363CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1095/biolreprod.111.098251info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386151/info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/biolreprod/article/86/6/191,%201-9/2530732info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:44:39Zoai:ri.conicet.gov.ar:11336/216458instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:44:39.892CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
title Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
spellingShingle Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
Blois, Sandra M.
implantation
pregnancy
trophoblast
angiogenesis
pregnancy specific glycoprotein 22
title_short Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
title_full Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
title_fullStr Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
title_full_unstemmed Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
title_sort Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.
dc.creator.none.fl_str_mv Blois, Sandra M.
Tirado González, Irene
Wu, Julie
Barrientos, Gabriela Laura
Johnson, Briana
Warren, James
Freitag, Nancy
Klapp, Burghard F.
Irmak, Ster
Ergun, Suleyman
Dveskler, Gabriela S.
author Blois, Sandra M.
author_facet Blois, Sandra M.
Tirado González, Irene
Wu, Julie
Barrientos, Gabriela Laura
Johnson, Briana
Warren, James
Freitag, Nancy
Klapp, Burghard F.
Irmak, Ster
Ergun, Suleyman
Dveskler, Gabriela S.
author_role author
author2 Tirado González, Irene
Wu, Julie
Barrientos, Gabriela Laura
Johnson, Briana
Warren, James
Freitag, Nancy
Klapp, Burghard F.
Irmak, Ster
Ergun, Suleyman
Dveskler, Gabriela S.
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv implantation
pregnancy
trophoblast
angiogenesis
pregnancy specific glycoprotein 22
topic implantation
pregnancy
trophoblast
angiogenesis
pregnancy specific glycoprotein 22
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Mouse and human pregnancy-specific glycoproteins (PSG) are known to exert immunomodulatory functions during pregnancy by inducing maternal leukocytes to secrete anti-inflammatory cytokines that promote a tolerogenic decidual microenvironment. Many such anti-inflammatory mediators also function as proangiogenic factors, which, along with the reported association of murine PSG with the uterine vasculature, suggest that PSG may contribute to the vascular adaptations necessary for successful implantation and placental development. We observed that PSG22 is strongly expressed around the embryonic crypt on Gestation Day 5.5, indicating that trophoblast giant cells are the main source of PSG22 during the early stages of pregnancy. PSG22 treatment up-regulated the secretion of transforming growth factor beta 1 and vascular endothelial growth factor A (VEGFA) in murine macrophages, uterine dendritic cells, and natural killer cells. A possible role of PSGs in uteroplacental angiogenesis is further supported by the finding that incubation of endothelial cells with PSG22 resulted in the formation of tubes in the presence and absence of VEGFA. We determined that PSG22, like human PSG1 and murine PSG17 and PSG23, binds to the heparan sulfate chains in syndecans. Therefore, our findings indicate that despite the independent evolution and expansion of human and rodent PSG, members in both families have conserved functions that include their ability to induce anti-inflammatory cytokines and proangiogenic factors as well as to induce the formation of capillary structures by endothelial cells. In summary, our results indicate that PSG22, the most abundant PSG expressed during mouse early pregnancy, is likely a major contributor to the establishment of a successful pregnancy.
Fil: Blois, Sandra M.. University Medicine of Berlin; Alemania
Fil: Tirado González, Irene. University Medicine of Berlin; Alemania
Fil: Wu, Julie. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Barrientos, Gabriela Laura. University Medicine of Berlin; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Johnson, Briana. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Warren, James. Uniformed Services University of the Health Sciences; Estados Unidos
Fil: Freitag, Nancy. University Medicine of Berlin; Alemania
Fil: Klapp, Burghard F.. University Medicine of Berlin; Alemania
Fil: Irmak, Ster. University of Duisburg Essen; Alemania
Fil: Ergun, Suleyman. Julius Maximilians Universitat Wurzburg. Biozentrum; Alemania
Fil: Dveskler, Gabriela S.. Uniformed Services University of the Health Sciences; Estados Unidos
description Mouse and human pregnancy-specific glycoproteins (PSG) are known to exert immunomodulatory functions during pregnancy by inducing maternal leukocytes to secrete anti-inflammatory cytokines that promote a tolerogenic decidual microenvironment. Many such anti-inflammatory mediators also function as proangiogenic factors, which, along with the reported association of murine PSG with the uterine vasculature, suggest that PSG may contribute to the vascular adaptations necessary for successful implantation and placental development. We observed that PSG22 is strongly expressed around the embryonic crypt on Gestation Day 5.5, indicating that trophoblast giant cells are the main source of PSG22 during the early stages of pregnancy. PSG22 treatment up-regulated the secretion of transforming growth factor beta 1 and vascular endothelial growth factor A (VEGFA) in murine macrophages, uterine dendritic cells, and natural killer cells. A possible role of PSGs in uteroplacental angiogenesis is further supported by the finding that incubation of endothelial cells with PSG22 resulted in the formation of tubes in the presence and absence of VEGFA. We determined that PSG22, like human PSG1 and murine PSG17 and PSG23, binds to the heparan sulfate chains in syndecans. Therefore, our findings indicate that despite the independent evolution and expansion of human and rodent PSG, members in both families have conserved functions that include their ability to induce anti-inflammatory cytokines and proangiogenic factors as well as to induce the formation of capillary structures by endothelial cells. In summary, our results indicate that PSG22, the most abundant PSG expressed during mouse early pregnancy, is likely a major contributor to the establishment of a successful pregnancy.
publishDate 2012
dc.date.none.fl_str_mv 2012-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/216458
Blois, Sandra M.; Tirado González, Irene; Wu, Julie; Barrientos, Gabriela Laura; Johnson, Briana; et al.; Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.; Society for the Study of Reproduction; Biology Of Reproduction (online); 86; 6; 6-2012; 1-9
0006-3363
CONICET Digital
CONICET
url http://hdl.handle.net/11336/216458
identifier_str_mv Blois, Sandra M.; Tirado González, Irene; Wu, Julie; Barrientos, Gabriela Laura; Johnson, Briana; et al.; Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast cells modulates angiogenesis in mice.; Society for the Study of Reproduction; Biology Of Reproduction (online); 86; 6; 6-2012; 1-9
0006-3363
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1095/biolreprod.111.098251
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386151/
info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/biolreprod/article/86/6/191,%201-9/2530732
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Society for the Study of Reproduction
publisher.none.fl_str_mv Society for the Study of Reproduction
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268681942335488
score 13.13397